Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bridges

Showing results (241-250 of 278) with videos related to

Pageof 28
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 4, 2018
Outcomes of immunosuppression minimization and withdrawal early after liver transplantationAbraham Shaked, Michele R DesMarais, Heather Kopetskie, et al.
Journal of the American College of Cardiology|July 6, 2019
Accelerated Allograft Vasculopathy With Rituximab After Cardiac TransplantationRandall C Starling, Brian Armstrong, Nancy D Bridges, et al.
Transplantation|December 1, 2017
Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17Geovani Faddoul, Girish N Nadkarni, Nancy D Bridges, et al.
Immunohorizons|September 19, 2025
Genetic deletion of Alx/Fpr2 differentially regulates pulmonary inflammation in the absence and presence of acute lung injuryRafia Virk, Madeline Behee, Abrar Al-Shaer, et al.
Nature Communications|February 9, 2022
Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimerZhi Yang, Kim-Marie A Dam, Michael D Bridges, et al.
JAMA|January 19, 2012
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplantsSandy Feng, Udeme D Ekong, Steven J Lobritto, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 24, 2013
Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injuryD E Hricik, P Nickerson, R N Formica, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2024
Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trialJames F Markmann, Bryna E Burrell, Jonathan S Bromberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2015
Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter StudyD E Hricik, J Augustine, P Nickerson, et al.
Medrxiv : the Preprint Server for Health Sciences|October 1, 2025
Development of a Flexible Multiplex Urine RNA Assay for Detection and Differentiation of Kidney Allograft InjuryKaren S Keslar, Wenjie Xu, Anna A Zmijewska, et al.
Pageof 28

Showing results (241-250 of 278) with videos related to

Sort By:
Pageof 28
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 4, 2018
Outcomes of immunosuppression minimization and withdrawal early after liver transplantationAbraham Shaked, Michele R DesMarais, Heather Kopetskie, et al.
Journal of the American College of Cardiology|July 6, 2019
Accelerated Allograft Vasculopathy With Rituximab After Cardiac TransplantationRandall C Starling, Brian Armstrong, Nancy D Bridges, et al.
Transplantation|December 1, 2017
Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17Geovani Faddoul, Girish N Nadkarni, Nancy D Bridges, et al.
Immunohorizons|September 19, 2025
Genetic deletion of Alx/Fpr2 differentially regulates pulmonary inflammation in the absence and presence of acute lung injuryRafia Virk, Madeline Behee, Abrar Al-Shaer, et al.
Nature Communications|February 9, 2022
Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimerZhi Yang, Kim-Marie A Dam, Michael D Bridges, et al.
JAMA|January 19, 2012
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplantsSandy Feng, Udeme D Ekong, Steven J Lobritto, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 24, 2013
Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injuryD E Hricik, P Nickerson, R N Formica, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2024
Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trialJames F Markmann, Bryna E Burrell, Jonathan S Bromberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2015
Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter StudyD E Hricik, J Augustine, P Nickerson, et al.
Medrxiv : the Preprint Server for Health Sciences|October 1, 2025
Development of a Flexible Multiplex Urine RNA Assay for Detection and Differentiation of Kidney Allograft InjuryKaren S Keslar, Wenjie Xu, Anna A Zmijewska, et al.
Pageof 28